Skip to main content
Stephen Schuster, MD, Hematology, Philadelphia, PA

StephenJSchusterMD

Hematology • Philadelphia, PA

Hematologic Oncology

Professor of Medicine, University of Pennsylvania

Join to view full profile

Dr. Schuster is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Schuster's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    Perelman Center for Advanced Medicine, 12th Floor
    Philadelphia, PA 19104
    Phone+1 215-662-3914

Summary

  • Dr. Stephen Schuster is a hematologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center. He received his medical degree from Sidney Kimmel Medical College at Thomas Jefferson University and has been in practice 36 years. He specializes in hematologic oncology and is experienced in hematologic oncology and leukemia. He has more than 100 publications and over 500 citings.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1988 - 1988
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1984 - 1988
  • Pennsylvania Hospital of the University of Pennsylvania Health System
    Pennsylvania Hospital of the University of Pennsylvania Health SystemResidency, Internal Medicine, 1981 - 1984
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1981

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2024 - Present
  • PA State Medical License
    PA State Medical License 1982 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • Philadelphia Magazine Castle Connolly, 2010-2014
  • America's Top Doctors for Cancer Castle Connolly, 2010-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • LRPAP1 Is a Frequent Proliferation-Inducing Antigen of BCRs of Mantle Cell Lymphomas and Can Be Used for Specific Therapeutic Targeting  
    Stephen J Schuster, Mariusz Wasik, Nature
  • Real World Outcomes and Management Strategies for Venetoclax-Treated Chronic Lymphocytic Leukemia Patients in the United States  
    Arun K Singavi, Andrew Zelenetz, Nicole Lamanna, Bruce D Cheson, Richard R Furman, Jakub Svoboda, Stephen J Schuster, John N Allan, Chaitra S Ujjani, Haematologica
  • Non-Viral RNA Chimeric Antigen Receptor Modified T Cells in Patients with Hodgkin Lymphoma  
    Stephan A Grupp, Sunita Dwivedy Nasta, Susan R Rheingold, Daniel J Landsburg, Carl H June, Jakub Svoboda, Stephen J Schuster, Saar I Gill, David L Porter, Bruce L Levine, Blood

Abstracts/Posters

  • A Characterization of Bridging Therapies Leading up to Commercial CAR T-Cell Therapy
    Stephen J. Schuster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies
    Stephen J. Schuster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Treatment Discontinuation Patterns for Patients with CLL in the Real-World Settings: Results from a Multi-Center Study
    Stephen J. Schuster, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Advances in CAR T-Cell Therapy for Leukemia, Lymphoma, and Myeloma: Where We Are and Where We Are Going 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Sustained Disease Control for Adult Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: An Updated Analysis of Juliet, a Global Pivotal Phase 2 Trial o... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • CD19-Directed CAR T-Cell (CTL019) Product Viability and Clinical Outcomes in Non-Hodgkin Lymphomas and B-Cell Acute Lymphoblastic Leukemia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Authored Content

  • Interleukin-18 Secreting Autologous Anti-CD19 CAR T-cells (huCART19-IL18) in Patients with Non-Hodgkin Lymphomas Relapsed or Refractory to Prior CAR T-cell TherapyDecember 2022

Press Mentions

  • Around the Nation: FDA Grants Expanded Approval for CAR-T Therapy
    Around the Nation: FDA Grants Expanded Approval for CAR-T TherapyJune 2nd, 2022
  • FDA Approves Novartis Kymriah® CAR-T Cell Therapy for Adult Patients with Relapsed or Refractory Follicular Lymphoma
    FDA Approves Novartis Kymriah® CAR-T Cell Therapy for Adult Patients with Relapsed or Refractory Follicular LymphomaMay 28th, 2022
  • Where Does CAR T-cell Cancer Therapy Stand After Its FDA Approval?
    Where Does CAR T-cell Cancer Therapy Stand After Its FDA Approval?August 4th, 2021
  • Join now to see all

Dr. Stephen Schuster, Dr. Stephen Schuster, MD, Dr. S Schuster, Dr. Stephen J Schuster